JP4960100B2 - 口腔および上気道の疾患を治療するための組成物 - Google Patents
口腔および上気道の疾患を治療するための組成物 Download PDFInfo
- Publication number
- JP4960100B2 JP4960100B2 JP2006540228A JP2006540228A JP4960100B2 JP 4960100 B2 JP4960100 B2 JP 4960100B2 JP 2006540228 A JP2006540228 A JP 2006540228A JP 2006540228 A JP2006540228 A JP 2006540228A JP 4960100 B2 JP4960100 B2 JP 4960100B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- phloroglucinols
- composition according
- anthocyanosides
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
[発明の開示]
本発明は、
a)アントシアノシド類、および/または
b)プロシアニジン類、および
c)フロログルシノール類、
を含む、口腔および上気道の疾患の治療に有用な組成物に関する。
実施例1−錠剤
各500mg錠剤は、以下を含む。
(アントシアニジン類25%) 60mg
ホップ抽出物
(フロログルシノール類60%) 10mg
大豆レシチン
(ホスファチジルコリン30%) 30mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
スクロース 200mg
マルトデキストリン 150mg
アラビアゴム 15mg
ステアリン酸マグネシウム 5mg
実施例II−錠剤
各500mg錠剤は、以下を含む。
(プロシアニジン類95%) 80mg
ホップ抽出物
(フロログルシノール類60%) 10mg
大豆レシチン
(ホスファチジルコリン30%) 30mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
マンニトール 320mg
ポビドン 20mg
二酸化ケイ素 5mg
ステアリン酸マグネシウム 5mg
実施例III−錠剤
各500mg錠剤は、以下を含む。
(プロシアニジン類95%) 80mg
ギンバイカ親油性抽出物
(ミルトクプロン35%) 10mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
マルトデキストリン 332mg
サッカリンナトリウム 3mg
アラビアゴム 30mg
タルク 10mg
ステアリン酸マグネシウム 5mg
実施例IV−錠剤
各500mg錠剤は、以下を含む。
(アントシアニジン類25%) 60mg
ギンバイカ親油性抽出物
(ミルトクプロン35%) 10mg
大豆レシチン
(ホスファチジルコリン30%) 30mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
スクロース 330mg
トラガカントガム 20mg
二酸化ケイ素 5mg
ステアリン酸マグネシウム 5mg
実施例V−錠剤
各500mg錠剤は、以下を含む。
(プロシアニドールオリゴマー類70%) 80mg
ホップ抽出物
(フロログルシノール類60%) 10mg
大豆レシチン
(ホスファチジルコリン30%) 30mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
マンニトール 320mg
ポビドン 20mg
二酸化ケイ素 5mg
ステアリン酸マグネシウム 5mg
実施例VI−錠剤
各500mg錠剤は、以下を含む。
(プロシアニドールオリゴマー類70%) 80mg
セイヨウオトギリソウ抽出物
(フロログルシノール類60%) 10mg
大豆レシチン
(ホスファチジルコリン30%) 30mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
マンニトール 320mg
ポビドン 20mg
二酸化ケイ素 5mg
ステアリン酸マグネシウム 5mg
実施例VII−チューイングガム
各2000mgチューイングガムは以下を含む。
(プロシアニジン95%) 80mg
ギンバイカ親油性抽出物
(ミルトクプロン30%) 10mg
グリチルリチン抽出物
(グリチルリチン酸10%) 20mg
ミント精油 10mg
ガムベース 1598mg
キシリトール 250mg
アスパルテーム 2mg
ステアリン酸マグネシウム 15mg
タルク 15mg
Claims (14)
- a)アントシアノシド類およびフロログルシノール類、または
b)アントシアノシド類、プロシアニジン類およびフロログルシノール類、
を含む、口腔内の細菌付着の軽減または口腔腐生感染症を治療するための組成物。 - 前記アントシアノシド類が、Vaccinium myrtillus抽出物に由来する請求項1に記載の組成物。
- 前記プロシアニジン類が、ヨーロッパブドウ抽出物またはチヤノキ抽出物、またはこれらを含む他の食用植物に由来する請求項1に記載の組成物。
- 前記フロログルシノール類が、オトギリソウ属の種、ギンバイカ属の種、またはホップの抽出物に由来する請求項1に記載の組成物。
- 前記フロログルシノール類が、セイヨウオトギリソウまたはギンバイカの抽出物、あるいはホップのα酸とβ酸とに富んだ画分に由来する請求項4に記載の組成物。
- ホップからの前記β酸画分がコルプロンとして発現する20〜80%のフロログルシノール類を含み、前記α酸画分がフムロンを20〜80%含む、請求項5に記載の組成物。
- ホップから調製した前記β酸画分がコルプロンとして発現する60%のフロログルシノール類を含み、前記α酸画分がフムロンを60%含む、請求項6に記載の組成物。
- 前記オトギリソウ属の種の抽出物が、20〜80%の範囲のフロログルシノール類含有量のセイヨウオトギリソウ抽出物である請求項5に記載の組成物。
- 前記セイヨウオトギリソウ抽出物における前記フロログルシノール類の含有量が、60%である請求項8に記載の組成物。
- 前記ギンバイカ抽出物が、二酸化炭素抽出法によって、235〜260バールの範囲の圧力、および40〜60℃の範囲の温度の条件下で、前記ギンバイカの葉から調製された請求項5に記載の組成物。
- 前記ギンバイカ抽出物が、ミルトクモロン35%の含有量を有する請求項10に記載の組成物。
- 前記組成物が、さらに精油を含む請求項1から11のいずれかに記載の組成物。
- 前記精油が、ミント油である請求項12に記載の組成物。
- 口腔内の細菌付着の軽減または口腔腐生感染症を治療するための薬剤を調製するための
a)アントシアノシド類およびフロログルシノール類、または
b)アントシアノシド類、プロシアニジン類およびフロログルシノール類、
の組合せの使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2003A002287 | 2003-11-24 | ||
IT002287A ITMI20032287A1 (it) | 2003-11-24 | 2003-11-24 | Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie |
PCT/EP2004/012472 WO2005053719A2 (en) | 2003-11-24 | 2004-11-04 | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007512268A JP2007512268A (ja) | 2007-05-17 |
JP4960100B2 true JP4960100B2 (ja) | 2012-06-27 |
Family
ID=34640361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006540228A Expired - Fee Related JP4960100B2 (ja) | 2003-11-24 | 2004-11-04 | 口腔および上気道の疾患を治療するための組成物 |
Country Status (21)
Country | Link |
---|---|
US (1) | US7910139B2 (ja) |
EP (1) | EP1687015B1 (ja) |
JP (1) | JP4960100B2 (ja) |
KR (1) | KR101181119B1 (ja) |
CN (1) | CN1886147A (ja) |
AT (1) | ATE454167T1 (ja) |
AU (1) | AU2004294688B2 (ja) |
CA (1) | CA2546926C (ja) |
DE (1) | DE602004025031D1 (ja) |
DK (1) | DK1687015T3 (ja) |
ES (1) | ES2335414T3 (ja) |
IL (1) | IL175845A0 (ja) |
IT (1) | ITMI20032287A1 (ja) |
NO (1) | NO339625B1 (ja) |
NZ (1) | NZ547396A (ja) |
PL (1) | PL1687015T3 (ja) |
PT (1) | PT1687015E (ja) |
RU (1) | RU2369401C2 (ja) |
SG (1) | SG148194A1 (ja) |
SI (1) | SI1687015T1 (ja) |
WO (1) | WO2005053719A2 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2632684A1 (en) * | 2005-12-09 | 2007-06-14 | Metaproteomics, Llc | Protein kinase modulation by hops and acacia products |
EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
JPWO2008026473A1 (ja) * | 2006-08-31 | 2010-01-21 | アサヒビール株式会社 | ホップ製剤の製造方法、ホップ製剤、抗炎症剤、飲食品および口腔用品 |
GB0623619D0 (en) * | 2006-11-27 | 2007-01-03 | Mars Uk Ltd | Composition |
ITSS20090007A1 (it) * | 2009-03-25 | 2010-09-25 | Sardinia Res And Dev S R L | Utilizzo dell'estratto di myrtus communis per la terapia dell'influenza tipo a. |
IT1402018B1 (it) | 2010-10-11 | 2013-08-28 | Indena Spa | Formulazioni per il trattamento delle affezioni delle prime vie respiratorie. |
GB201108384D0 (en) | 2011-05-18 | 2011-06-29 | Mars Inc | Chew |
ITMI20111671A1 (it) * | 2011-09-16 | 2013-03-17 | Indena Spa | Composizioni per il trattamento di ulcere periferiche di varia origine |
GB201310691D0 (en) | 2013-06-14 | 2013-07-31 | Mars Inc | Assay |
ITUA20161822A1 (it) * | 2016-03-18 | 2017-09-18 | Indena Spa | Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago |
US11013673B2 (en) | 2016-11-03 | 2021-05-25 | Repairogen Corp. | Cosmetic compositions containing quinones and their topical use on skin and hair |
BR112019009089A2 (pt) | 2016-11-03 | 2019-07-16 | Univ Cornell | composição cosmética, método para tratar queimaduras solares, sinais de envelhecimento ou uma combinação destes em mamíferos e método para aprimorar reparo de dna |
WO2019213494A1 (en) | 2018-05-03 | 2019-11-07 | Repairogen Corp | Cosmetic compositions containing quinones and their topical use on skin and hair |
CN109172556A (zh) * | 2018-10-30 | 2019-01-11 | 何凤姣 | 一种治疗口腔溃疡的组合物及其制备方法 |
EP4037780A2 (en) | 2019-09-30 | 2022-08-10 | The Procter & Gamble Company | Oral care compositions with anticaries activity |
WO2021062607A1 (en) | 2019-09-30 | 2021-04-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
WO2023057556A1 (de) * | 2021-10-07 | 2023-04-13 | Dr. Eckel Vermögensverwaltung Gmbh | Zusammensetzung zur reduzierung der konzentration von viren und des afrikanischen schweinepest-virus (african swine fever virus, asfv) in tierfutter und einstreumaterial für ställe |
EP4176730A1 (de) * | 2021-10-07 | 2023-05-10 | Dr. Eckel Vermögensverwaltung GmbH | Zusammensetzung zur reduzierung der konzentration von viren und des afrikanischen schweinepest-virus (african swine fever virus, asfv) in tierfutter und einstreumaterial für ställe |
KR102517602B1 (ko) * | 2022-10-31 | 2023-04-04 | 한국 한의학 연구원 | 포도나무 줄기 및 유래성분을 함유하는 항바이러스 조성물 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1589294A (en) * | 1976-09-08 | 1981-05-13 | Inverni Della Beffa Spa | Pharmaceutical compositions containing anthocyanidines |
US4503256A (en) * | 1981-07-02 | 1985-03-05 | Noristan Limited | Phlorophenone derivatives, processes for preparing such compounds, uses and pharmaceutical compositions of phlorophenone compounds |
FR2571257A1 (fr) * | 1984-08-06 | 1986-04-11 | Gros Pierre | Composition destinee a l'humidification de la muqueuse rhino-pharyngee |
SU1373398A1 (ru) * | 1986-07-24 | 1988-02-15 | Технологическо-Конструкторский Институт Научно-Производственного Агропромышленного Объединения "Яловены" | Безалкогольный газированный напиток |
US5650432A (en) * | 1995-03-24 | 1997-07-22 | Jlb, Inc. | Method of treating or preventing non-viral microbial infection |
JPH06179609A (ja) * | 1992-12-14 | 1994-06-28 | Lion Corp | 口腔用組成物 |
US5370863A (en) * | 1992-12-16 | 1994-12-06 | Miller Brewing Company | Oral care compositions containing hop acids and method |
US5474774A (en) * | 1994-03-25 | 1995-12-12 | Jlb, Inc. | Adhesion inhibiting composition |
JPH0820518A (ja) | 1994-07-06 | 1996-01-23 | Shiseido Co Ltd | 染毛剤組成物 |
JP2901879B2 (ja) * | 1994-07-12 | 1999-06-07 | 株式会社ポッカコーポレーション | 抗菌剤 |
JP3450080B2 (ja) * | 1995-02-01 | 2003-09-22 | 有限会社野々川商事 | プロシアニジンを配合した健康食品および医薬品 |
NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
JP3547835B2 (ja) * | 1995-03-27 | 2004-07-28 | 株式会社ロッテ | 喉炎症・溶血毒の予防・治療剤およびこれを含有する口腔用組成物 |
WO1997041137A1 (en) * | 1996-04-17 | 1997-11-06 | Unifob | Use of anthocyanidin and anthocyanidin derivatives |
US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
US6224906B1 (en) * | 1999-08-31 | 2001-05-01 | Natreon Inc. | St. John's wort composition |
US6379720B1 (en) * | 2000-07-18 | 2002-04-30 | Nalco Chemical Company | Compositions containing hops extract and their use in water systems and process streams to control biological fouling |
KR20030040451A (ko) * | 2000-09-12 | 2003-05-22 | 닛카우위스키가부시키가이샤 | 야생사과 열매 폴리페놀 및 그의 제조방법 |
WO2002092028A2 (en) * | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Oral care compositions |
US6576269B1 (en) * | 2001-09-06 | 2003-06-10 | Alexander Y. Korneyev | Treating open skin lesions using extract of sea buckthorn |
US6638542B2 (en) * | 2001-09-20 | 2003-10-28 | Nutricia N.V. | Reducing appetite in mammals by administering procyanidin and hydroxycitric acid |
US6623768B1 (en) * | 2002-04-16 | 2003-09-23 | Yousry M. A. Naguib | Pharmaceutically active composition extracted from Ferula hermonis and process of its extraction |
CN1191848C (zh) * | 2002-12-23 | 2005-03-09 | 桂林三金药业股份有限公司 | 一种防治咽喉口腔疾病的中药制剂及其制备方法 |
-
2003
- 2003-11-24 IT IT002287A patent/ITMI20032287A1/it unknown
-
2004
- 2004-11-04 NZ NZ547396A patent/NZ547396A/en unknown
- 2004-11-04 EP EP04819578A patent/EP1687015B1/en active Active
- 2004-11-04 SG SG200808637-3A patent/SG148194A1/en unknown
- 2004-11-04 RU RU2006117777/15A patent/RU2369401C2/ru active
- 2004-11-04 JP JP2006540228A patent/JP4960100B2/ja not_active Expired - Fee Related
- 2004-11-04 PL PL04819578T patent/PL1687015T3/pl unknown
- 2004-11-04 ES ES04819578T patent/ES2335414T3/es active Active
- 2004-11-04 DK DK04819578.8T patent/DK1687015T3/da active
- 2004-11-04 WO PCT/EP2004/012472 patent/WO2005053719A2/en active Application Filing
- 2004-11-04 CA CA2546926A patent/CA2546926C/en not_active Expired - Fee Related
- 2004-11-04 KR KR1020067008858A patent/KR101181119B1/ko active IP Right Grant
- 2004-11-04 CN CNA2004800345868A patent/CN1886147A/zh active Pending
- 2004-11-04 DE DE602004025031T patent/DE602004025031D1/de active Active
- 2004-11-04 SI SI200431347T patent/SI1687015T1/sl unknown
- 2004-11-04 PT PT04819578T patent/PT1687015E/pt unknown
- 2004-11-04 AT AT04819578T patent/ATE454167T1/de active
- 2004-11-04 AU AU2004294688A patent/AU2004294688B2/en not_active Ceased
- 2004-11-04 US US10/580,190 patent/US7910139B2/en not_active Expired - Fee Related
-
2006
- 2006-05-23 NO NO20062355A patent/NO339625B1/no not_active IP Right Cessation
- 2006-05-23 IL IL175845A patent/IL175845A0/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101181119B1 (ko) | 2012-09-14 |
CN1886147A (zh) | 2006-12-27 |
DK1687015T3 (da) | 2010-05-03 |
US7910139B2 (en) | 2011-03-22 |
WO2005053719A2 (en) | 2005-06-16 |
ATE454167T1 (de) | 2010-01-15 |
ITMI20032287A1 (it) | 2005-05-25 |
PL1687015T3 (pl) | 2010-05-31 |
DE602004025031D1 (de) | 2010-02-25 |
US20070104661A1 (en) | 2007-05-10 |
EP1687015B1 (en) | 2010-01-06 |
IL175845A0 (en) | 2006-10-05 |
NO339625B1 (no) | 2017-01-16 |
NZ547396A (en) | 2009-04-30 |
CA2546926A1 (en) | 2005-06-16 |
CA2546926C (en) | 2014-09-23 |
AU2004294688B2 (en) | 2010-07-22 |
ES2335414T3 (es) | 2010-03-26 |
NO20062355L (no) | 2006-05-23 |
KR20070007252A (ko) | 2007-01-15 |
AU2004294688A1 (en) | 2005-06-16 |
SG148194A1 (en) | 2008-12-31 |
RU2369401C2 (ru) | 2009-10-10 |
EP1687015A2 (en) | 2006-08-09 |
WO2005053719A3 (en) | 2005-09-22 |
SI1687015T1 (sl) | 2010-04-30 |
PT1687015E (pt) | 2010-01-27 |
JP2007512268A (ja) | 2007-05-17 |
RU2006117777A (ru) | 2007-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4960100B2 (ja) | 口腔および上気道の疾患を治療するための組成物 | |
AU2005315921B2 (en) | Compositions comprising extracts from Sanguinaria or Macleaya | |
EP2046324B1 (en) | Treatment and prevention of mucositis by anthocyanidin derivatives | |
AU2011315708B2 (en) | Formulations for the treatment of disorders of the upper respiratory tract | |
RU2518738C2 (ru) | Композиции для лечения заболеваний верхних дыхательных путей и симптомокомплекса гриппа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110302 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110602 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110609 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110901 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120104 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120221 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120322 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150330 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4960100 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |